Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells.

Medical Oncology
Aimin ZhangXiangtie Li

Abstract

Antiapoptosis and invasion are the causes for the failure of conventional radiotherapy and chemotherapy in human renal carcinomas. Osteopontin (OPN), a ligand for vß3 integrin and CD44 receptors, is a phosphorylated glycoprotein with diverse functions including tumorigenesis and tumor cell metastasis. Recently, OPN has been detected in human renal carcinomas and assessed as a potential prognostic marker of renal carcinomas. However, the function and mechanism of OPN in renal carcinomas remain unknown. In this study, we used OPN siRNA to silence the expression of OPN in renal carcinoma Caki-1 cells. Silent effect showed that sequence-specific siRNA targeting OPN suppressed OPN mRNA expression by 81% and OPN protein level by 91% in vitro. The apoptosis ability was significantly increased while the invasion ability was decreased in Caki-1 cells transfected with OPN siRNA. Western blot demonstrated that the effects of OPN silence were significantly accompanied by the activation of mitochondria-related apoptosis pathway involving cytochrome c, Apaf-1, cleaved caspase-3 and Bcl-2/Bax, and the downregulation of invasion-related proteins of MMP-2 and uPA expression. These results suggest that the downregulation of OPN expression can in...Continue Reading

References

Nov 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A F ChambersA G Casson
May 16, 1998·International Journal of Cancer. Journal International Du Cancer·T UeE Tahara
Apr 24, 1999·Experimental Nephrology·S R Rittling, D T Denhardt
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·N ShijuboS Abe
Nov 1, 2001·Biochimica Et Biophysica Acta·A N Webber, W Lubitz
Feb 5, 2002·Biochimica Et Biophysica Acta·G F Weber
Apr 10, 2002·Pathology International·Masahiro GotohSetsuo Hirohashi
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amnon ZismanArie S Belldegrun
Aug 19, 2006·Journal of Surgical Oncology·Koviljka MatusanKsenija Lucin
May 5, 2007·Journal of Cancer Research and Clinical Oncology·Azizbek RamankulovKlaus Jung
Sep 23, 2008·AJR. American Journal of Roentgenology·Chaan S NgCarl M Sandler
Jan 1, 1998·Journal of Cellular Biochemistry·David T Denhardt, Masaki Noda

❮ Previous
Next ❯

Citations

Apr 14, 2010·Cancer Metastasis Reviews·Claudia ChiodoniSabina Sangaletti
May 15, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Adil AnwarKurt R Stenmark
Jan 29, 2011·Stroke; a Journal of Cerebral Circulation·Wanqiu ChenJohn H Zhang
Jun 21, 2014·World Journal of Surgical Oncology·Kai-Hsi HsuYan-Shen Shan
Oct 16, 2013·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J C HahneA Hönig
Sep 28, 2013·Critical Reviews in Oncology/hematology·Thomas E KrugerJinxi Wang
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Puthucode Venkatakrishnan Ramachandran, Savarimuthu Ignacimuthu
Jul 12, 2011·Urology·William J F GreenHari L Ratan
Feb 15, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Wang LikuiWen Yan
Dec 12, 2018·International Journal of Oncology·Etel R P GimbaGabriela Nestal De Moraes
Sep 5, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yong WangDan Yue

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.